CI

Here Are Some Essential Facts About Cigna

More and more people are talking about Cigna over the last few weeks. Is it worth buying the Medical Specialities stock at a price of $296.62? Only time will tell. The information below will give you a basic idea of what this investment may entail:

  • Cigna has moved -11.2% over the last year, and the S&P 500 logged a change of 22.9%

  • CI has an average analyst rating of buy and is -14.89% away from its mean target price of $348.52 per share

  • Its trailing earnings per share (EPS) is $17.72

  • Cigna has a trailing 12 month Price to Earnings (P/E) ratio of 16.7 while the S&P 500 average is 15.97

  • Its forward earnings per share (EPS) is $28.24 and its forward P/E ratio is 10.5

  • The company has a Price to Book (P/B) ratio of 1.9 in contrast to the S&P 500's average ratio of 2.95

  • Cigna is part of the Health Care sector, which has an average P/E ratio of 30.21 and an average P/B of 4.08

  • CI has reported YOY quarterly earnings growth of -47.2% and gross profit margins of 0.1%

  • The company has a free cash flow of $9.84 Billion, which refers to the total sum of all its inflows and outflows of cash over the last quarter

  • The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS